Skip to main content
DNA Labs India

DICER1 Gene Pleuropulmonary blastoma NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

DICER1 Gene Pleuropulmonary blastoma NGS Genetic Test

Short Name: DICER1 PPB NGS Test

Also known as: DICER1 Mutation Test, PPB Genetic Test, DICER1 Gene Sequencing

DICER1 Gene Pleuropulmonary blastoma NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks from sample receipt at the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic TestPediatric and Adult🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of this test is to identify pathogenic mutations in the DICER1 gene that increase the risk of developing pleuropulmonary blastoma (PPB) and other DICER1-related tumors. Early detection allows for timely medical intervention, regular monitoring, and genetic counseling for affected families. The test also aids in confirming a clinical diagnosis of PPB, guiding treatment decisions, and assessing risk in asymptomatic family members.

Test Code
6013
CPT Code
81479
ICD Code
C39.9
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks from sample receipt at the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation is required. However, a genetic counseling session is recommended prior to testing to discuss the implications of results. Please provide a detailed clinical history and family pedigree.

Method: Venipuncture or Fingerstick

Step 2

Laboratory Analysis

Blood sample will be collected by a trained phlebotomist. For FTA card, a simple fingerstick is sufficient. Ensure the sample is properly labeled.

Step 3

Report Delivery

No specific aftercare is needed. The sample will be transported to the laboratory for analysis. Results will be available in 3 to 4 weeks.

Timeline: 3 to 4 weeks from sample receipt at the laboratory.

Patient Instructions

1
Before the Test:No fasting required. However, a genetic counseling session is recommended to discuss the purpose, risks, and implications of testing.
2
During the Test:A blood sample will be collected or a fingerstick for FTA card. The procedure is quick and minimally invasive.
3
After the Test:You can resume normal activities immediately. Results will be shared via your preferred mode within 3-4 weeks.

About This Test

Who Should Get This Test

The primary purpose of this test is to identify pathogenic mutations in the DICER1 gene that increase the risk of developing pleuropulmonary blastoma (PPB) and other DICER1-related tumors. Early detection allows for timely medical intervention, regular monitoring, and genetic counseling for affected families. The test also aids in confirming a clinical diagnosis of PPB, guiding treatment decisions, and assessing risk in asymptomatic family members.

How to Prepare

  • For blood sample: Use EDTA tube, collect 3-5 ml of peripheral blood.
  • For FTA card: Apply one drop of blood onto the designated circle and allow to air dry.
  • Label the sample with patient name, date of birth, and collection date.
  • Maintain sample at ambient temperature during transport.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Early identification of DICER1 mutations is crucial for managing PPB risk. This test enables proactive surveillance and family counseling."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 ml blood or 1 drop on FTA card
ContainerEDTA tube or FTA card
Collection MethodVenipuncture or Fingerstick

Sample Stability

Blood in EDTA tube
FTA card
Extracted DNA
Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Insufficient sample volume
  • Improperly labeled sample
  • Sample exposed to extreme temperatures

Understanding Your Results

The interpretation of DICER1 gene test results should be performed by a qualified geneticist or oncologist. Results are reported as positive, negative, or variant of uncertain significance (VUS). A positive result indicates the presence of a pathogenic mutation associated with increased PPB risk. A negative result reduces but does not eliminate the possibility of PPB, especially if clinical suspicion is high. VUS results require further investigation and family segregation studies.
📊

Positive (Pathogenic variant detected)

Individual has an increased risk of developing PPB and other DICER1-related tumors. Regular surveillance and preventive measures are recommended. Family members should be offered testing.

📊

Negative (No pathogenic variant detected)

No DICER1 mutation identified. However, if clinical suspicion remains high, consider other genetic causes or re-evaluation.

📊

Variant of Uncertain Significance (VUS)

A genetic variant was found, but its clinical significance is unknown. Additional testing of family members may help clarify.

⚠️ When to Consult a Doctor:

Consult a doctor if your child exhibits persistent respiratory symptoms such as cough, shortness of breath, chest pain, fever, wheezing, weight loss, or fatigue. Also, if there is a family history of PPB or DICER1-related tumors, genetic counseling and testing are advised.

Limitations

  • This test detects mutations in the DICER1 gene only; other genetic causes of PPB are not evaluated.
  • Large deletions/duplications may not be detected by standard NGS; additional testing may be required.
  • Variants of uncertain significance (VUS) may be reported; further family studies may be needed.
  • Test results should be interpreted in the context of clinical findings and family history.

Risks & Considerations

  • Minimal risk of bruising or infection at the blood draw site
  • Psychological impact of genetic testing results
  • Potential for variant of uncertain significance causing anxiety

Interfering Factors

  • Poor sample quality or insufficient DNA
  • Contamination during sample collection
  • Recent blood transfusion (may dilute DNA)
  • Presence of hematological malignancies affecting DNA extraction

Compare With Similar Tests

TestDICER1 Gene Pleuropulmonary blastoma NGS Genetic TestDICER1 Single Gene SequencingComprehensive Cancer Panel
ComparisonDICER1 Gene Pleuropulmonary blastoma NGS Genetic Test

Frequently Asked Questions

What is the DICER1 gene and its role in PPB?
The DICER1 gene provides instructions for making an enzyme that processes microRNAs, which regulate gene expression. Mutations in DICER1 can lead to uncontrolled cell growth, increasing the risk of pleuropulmonary blastoma (PPB) and other tumors.
Who should consider this test?
Children with symptoms suggestive of PPB, individuals with a family history of PPB or DICER1-related tumors, and those with personal history of DICER1-associated conditions.
How is the test performed?
A blood sample is collected (or a drop of blood on FTA card) and sent to the laboratory. DNA is extracted and analyzed using next-generation sequencing to detect mutations in the DICER1 gene.
What is the cost of the test?
The cost is INR 20,000, which includes home sample collection, laboratory analysis, and a detailed report.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after the sample reaches the laboratory.
Is fasting required before the test?
No, fasting is not required for this genetic test.
Can this test be done on children?
Yes, the test is suitable for children, especially those with symptoms or family history of PPB.
What does a positive result mean?
A positive result indicates the presence of a pathogenic DICER1 mutation, which increases the risk of developing PPB and other DICER1-related tumors. Regular surveillance and preventive measures are recommended.
What does a negative result mean?
A negative result means no pathogenic mutation was detected in the DICER1 gene. However, it does not completely rule out PPB, especially if clinical suspicion is high.
What is a variant of uncertain significance (VUS)?
A VUS is a genetic change whose impact on health is unknown. Further testing of family members may help clarify its significance.
Is genetic counseling provided?
Yes, genetic counseling is recommended and available to help interpret results and discuss implications for the patient and family.
Is home sample collection available?
Yes, we offer free home sample collection for online bookings across major cities in India.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.